Lv1
40 积分 2025-07-18 加入
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies
1个月前
已完结
Niacin for Reduction of Cardiovascular Risk
4个月前
已关闭
Future of angiopoietin-like protein 3 inhibitors as a therapeutic agent
4个月前
已完结
ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases
4个月前
已完结
ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis
4个月前
已完结
ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases
4个月前
已完结
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia: A Phase 2 Study
4个月前
已完结
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
4个月前
已完结
Supervised learning of high-confidence phenotypic subpopulations from single-cell data
5个月前
已完结
Genetics of Cholesterol and Coronary Disease Risk across Six Global Ancestries
5个月前
已完结
皖公网安备34019202002308
